BLC AND BLR1 AND IMMUNE FUNCTION AND DYSFUNCTION

BLC 和 BLR1 与免疫功能和功能障碍

基本信息

  • 批准号:
    6632078
  • 负责人:
  • 金额:
    $ 20.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-04-01 至 2004-03-31
  • 项目状态:
    已结题

项目摘要

Chemokines are well characterized as small chemotactic cytokines that recruit cells from the blood to sites of infection. Recent studies have uncovered a role for chemokines in cell trafficking through lymphoid tissues. In mice deficient in Burkitt's Lymphoma Receptor 1 (BLR1/CXC- R5), B cell follicles fail to form in spleen and Peyer's patches and inguinal lymph nodes do not develop. B-Lymphocyte Chemoattractant (BLC/BCA1), the only known ligand for BLR1, is expressed by follicular stromal cells in these tissues. How BLR1 and BLC function to organize cells in follicles is not understood. The long-term objective of this propose is to define the contribution of BLR1/BLC to cell migration and organization in both lymphoid and non-lymphoid tissues. The first of three aims seeks to determine if changes in BLR1 expression or BLC responsiveness contribute to the changes in B cell tropism that occur upon activation and differentiation. Similar studies will also be performed on T cells since T cell migration into follicles is essential for germinal center reactions and may also permit access to antigen trapped on follicular dendritic cells such as HIV in patients with AIDS. Aim 1 will also test if a splice variant of BLR1 in human macrophages is expressed in the mouse and will determine the BLC responsiveness of macrophage subsets. In Aim 2 the mouse BLC gene will be inactivated by gene targeting. BLC-deficient mice are important for reestablishing the role of BLC in follicular compartmentalization of B cells, for determining whether BLC is the only ligand for BLR1 and for characterizing whether BLC has functions in addition to a role in cell homing to follicles. The targeting construct will also introduce the green fluorescent protein gene (GFP) into the BLC locus to permit characterization of BLC expressing cells. In patients suffering chronic inflammatory diseases such as rheumatoid arthritis and diabetes, there are often large accumulations of B cells in the affected tissue. The third aim will explore whether BLC is expressed at sites of chronic inflammation in mouse models and, using the gene targeted mice, test to what extent BLC contributes to the inflammation. This aim will also test the effect of BLC expression to an ectopic site (the pancreatic islets) using a transgenic approach both to determine whether BLC is sufficient to promote follicle formation and to establish a system where the relationship between B cell accumulation and pathology can be studied.
趋化因子被很好地描述为小的趋化细胞因子 从血液中招募细胞到感染部位。最近的研究表明 发现趋化因子在细胞通过淋巴系统运输中的作用 纸巾。在Burkitt淋巴瘤受体1(BLR1/CXC-1)缺陷小鼠中 R5),B细胞滤泡不能在脾和Peyer‘s斑内形成, 腹股沟淋巴结不发育。B淋巴细胞趋化因子 (BLC/BCA1)是唯一已知的BLR1的配体,在卵泡中表达 这些组织中的基质细胞。BLR1和BLC如何进行组织 卵泡中的细胞还不清楚。这样做的长期目标是 建议定义BLR1/BLC对细胞迁移和 淋巴组织和非淋巴组织中的组织。第一个 三个目标试图确定BLR1表达或BLC的变化 反应性有助于B细胞趋向性的改变 在激活和分化时。类似的研究也将在 对T细胞进行手术,因为T细胞迁移到毛囊是必不可少的 用于生发中心反应,也可以允许访问抗原 艾滋病患者体内的滤泡树突状细胞,如HIV。 AIM 1还将测试人类巨噬细胞中BLR1的剪接变体是否 在小鼠中表达,并将确定BLC对 巨噬细胞亚群。在Aim 2中,小鼠BLC基因将通过以下方式失活 基因打靶。BLC缺陷小鼠对于重建 BLC在B细胞卵泡区域化中的作用 确定BLC是否是BLR1和For的唯一配体 表征BLC是否除了在细胞中的作用外还具有功能 归巢到毛囊。目标构造还将引入 绿色荧光蛋白基因(GFP)进入BLC基因座的许可 表达BLC的细胞的特性。在患有慢性疾病的患者中 炎症性疾病,如类风湿性关节炎和糖尿病 通常是在受影响的组织中大量积累B细胞。这个 第三个目标将探索BLC是否在慢性粒细胞白血病的部位表达 小鼠模型中的炎症,并使用该基因靶向的小鼠,测试 BLC在多大程度上促进了炎症。这一目标也将考验 BLC表达对异位胰岛的影响 使用转基因方法来确定BLC是否足够 促进卵泡的形成,并建立一种制度, 可以研究B细胞积聚与病理的关系。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jason G Cyster其他文献

Lymph node chemokines promote sustained T lymphocyte motility without triggering stable integrin adhesiveness in the absence of shear forces
在没有剪切力的情况下,淋巴结趋化因子促进持续的 T 淋巴细胞运动而不触发稳定的整合素黏附性。
  • DOI:
    10.1038/ni1499
  • 发表时间:
    2007-08-26
  • 期刊:
  • 影响因子:
    27.600
  • 作者:
    Eilon Woolf;Irina Grigorova;Adi Sagiv;Valentin Grabovsky;Sara W Feigelson;Ziv Shulman;Tanja Hartmann;Michael Sixt;Jason G Cyster;Ronen Alon
  • 通讯作者:
    Ronen Alon
The sphingosine 1-phosphate receptor S1P2 maintains the homeostasis of germinal center B cells and promotes niche confinement
鞘氨醇-1-磷酸受体 S1P2 维持生发中心 B 细胞的内环境稳定并促进小生境限制
  • DOI:
    10.1038/ni.2047
  • 发表时间:
    2011-06-05
  • 期刊:
  • 影响因子:
    27.600
  • 作者:
    Jesse A Green;Kazuhiro Suzuki;Bryan Cho;L David Willison;Daniel Palmer;Christopher D C Allen;Timothy H Schmidt;Ying Xu;Richard L Proia;Shaun R Coughlin;Jason G Cyster
  • 通讯作者:
    Jason G Cyster
B cell follicles and antigen encounters of the third kind
B 细胞滤泡与第三种抗原相遇
  • DOI:
    10.1038/ni.1946
  • 发表时间:
    2010-10-19
  • 期刊:
  • 影响因子:
    27.600
  • 作者:
    Jason G Cyster
  • 通讯作者:
    Jason G Cyster
Finding a way out: lymphocyte egress from lymphoid organs
寻找出路:淋巴细胞从淋巴器官流出
  • DOI:
    10.1038/ni1545
  • 发表时间:
    2007-11-16
  • 期刊:
  • 影响因子:
    27.600
  • 作者:
    Susan R Schwab;Jason G Cyster
  • 通讯作者:
    Jason G Cyster

Jason G Cyster的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jason G Cyster', 18)}}的其他基金

GPR35 function in the immune system
GPR35 在免疫系统中的功能
  • 批准号:
    10277281
  • 财政年份:
    2021
  • 资助金额:
    $ 20.1万
  • 项目类别:
GPR35 function in the immune system
GPR35 在免疫系统中的功能
  • 批准号:
    10415205
  • 财政年份:
    2021
  • 资助金额:
    $ 20.1万
  • 项目类别:
Predoctoral Training in Biomedical Sciences
生物医学博士前培训
  • 批准号:
    7890929
  • 财政年份:
    2009
  • 资助金额:
    $ 20.1万
  • 项目类别:
Cellular and Genetic Analysis of Lymphocyte Egress
淋巴细胞排出的细胞和遗传分析
  • 批准号:
    8079711
  • 财政年份:
    2007
  • 资助金额:
    $ 20.1万
  • 项目类别:
Cellular and Genetic Analysis of Lymphocyte Egress
淋巴细胞排出的细胞和遗传分析
  • 批准号:
    8462890
  • 财政年份:
    2007
  • 资助金额:
    $ 20.1万
  • 项目类别:
Cellular and Genetic Analysis of Lymphocyte Egress
淋巴细胞排出的细胞和遗传分析
  • 批准号:
    7623199
  • 财政年份:
    2007
  • 资助金额:
    $ 20.1万
  • 项目类别:
Cellular and Genetic Analysis of Lymphocyte Egress
淋巴细胞排出的细胞和遗传分析
  • 批准号:
    7298060
  • 财政年份:
    2007
  • 资助金额:
    $ 20.1万
  • 项目类别:
Cellular and Genetic Analysis of Lymphocyte Egress
淋巴细胞排出的细胞和遗传分析
  • 批准号:
    7812261
  • 财政年份:
    2007
  • 资助金额:
    $ 20.1万
  • 项目类别:
Cellular and Genetic Analysis of Lymphocyte Egress
淋巴细胞排出的细胞和遗传分析
  • 批准号:
    9066060
  • 财政年份:
    2007
  • 资助金额:
    $ 20.1万
  • 项目类别:
Cellular and Genetic Analysis of Lymphocyte Egress
淋巴细胞排出的细胞和遗传分析
  • 批准号:
    8662682
  • 财政年份:
    2007
  • 资助金额:
    $ 20.1万
  • 项目类别:

相似海外基金

Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2022
  • 资助金额:
    $ 20.1万
  • 项目类别:
    Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10581488
  • 财政年份:
    2022
  • 资助金额:
    $ 20.1万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574979-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 20.1万
  • 项目类别:
    University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10332251
  • 财政年份:
    2022
  • 资助金额:
    $ 20.1万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574984-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 20.1万
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574985-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 20.1万
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574978-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 20.1万
  • 项目类别:
    University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
  • 批准号:
    444149
  • 财政年份:
    2021
  • 资助金额:
    $ 20.1万
  • 项目类别:
    Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
  • 批准号:
    RGPIN-2015-05491
  • 财政年份:
    2021
  • 资助金额:
    $ 20.1万
  • 项目类别:
    Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2021
  • 资助金额:
    $ 20.1万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了